[Form 4] NV5 Global, Inc. Insider Trading Activity

Rhea-AI Filing Summary

NV5 Global, Inc. (NVEE) – Form 4 filing (08/06/2025)

Alexander A. Hockman, listed as “CEO Infrastructure,” reported the disposition (Code D) of his NV5 common shares on 08/04/2025 in connection with the closing of the company’s merger with Acuren Corporation. Under the Merger Agreement signed 14-May-2025, every NV5 share was automatically converted into:

• 1.1523 Acuren common shares
• US $10.00 in cash

All of Hockman’s outstanding restricted stock awards vested immediately before the effective time and were also exchanged for the same consideration, net of tax withholding. The filing shows 365,084 shares affected; following the conversion, no NV5 shares remain beneficiary-owned, indicating the issuer’s equity has been fully exchanged and NV5 will cease to exist as a stand-alone trading entity.

This Form 4 therefore documents the insider’s final disposition of NV5 stock and confirms consummation of the previously announced merger terms.

Positive

• Deal consummation provides holders US $10 cash plus 1.1523 Acuren shares per NV5 share, delivering liquidity and ongoing upside in the combined company.

Negative

• Loss of standalone NV5 exposure; investors must now rely on Acuren’s performance, with no information on exchange-ratio premium in this filing.

Insights

M&A Specialist

TL;DR — Filing confirms NV5’s cash-and-stock takeover by Acuren; insider’s 365k shares converted, signalling deal completion.

The Form 4 evidences the closing mechanics of the Acuren–NV5 merger. The cash component (US $10.00) combined with a 1.1523-share exchange ratio finalises total consideration for legacy NVEE holders. Insider conversion rather than open-market sale eliminates overhang risk and suggests all regulatory and shareholder approvals are complete. Material impact is on capital structure, not ongoing earnings, as NV5 equity will be retired.

Portfolio Manager

TL;DR — Insider exit via mandatory conversion; transaction confirms liquidity event but offers no view on combined entity value.

From a portfolio perspective, NVEE no longer trades independently. Holders now own Acuren shares plus cash, effectively crystalising returns. The absence of price data prevents assessment versus pre-deal market levels, so impact for legacy investors depends on prior entry price. Nonetheless, completion risk is now removed and proceeds are certain.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hockman Alexander A.

(Last) (First) (Middle)

200 SOUTH PARK RD.

SUITE 350

(Street)

HOLLYWOOD FL 33021

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NV5 Global, Inc. [ NVEE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO Infrastructure

3. Date of Earliest Transaction (Month/Day/Year)
08/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/04/2025		D		365,084	D	(1)	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Pursuant to the Agreement and Plan of Merger, dated as of May 14, 2025 (the "Merger Agreement"), by and among NV5 Global, Inc. (the "Company"), Acuren Corporation ("Acuren"), Ryder Merger Sub I, Inc. and Ryder Merger Sub II, Inc., each outstanding share of common stock of the Issuer was converted into the right to receive 1.1523 shares of Acuren common stock per share and $10.00 in cash per share (together, the "Merger Consideration"). In addition, pursuant to the Merger Agreement, any outstanding restricted stock award of NV5 held by the Reporting Person automatically vested in full in accordance with its terms immediately prior to the effective time of the mergers and converted into the right to receive the Merger Consideration, less applicable tax withholdings.

	/s/ MaryJo OBrien, as attorney in fact	08/06/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did NV5 (NVEE) insiders report in the Form 4 dated 08/06/2025?

CEO Infrastructure Alexander A. Hockman reported the disposition of 365,084 NV5 shares through conversion under the Acuren merger.

What consideration did NV5 shareholders receive in the Acuren merger?

Each NV5 share was exchanged for 1.1523 Acuren shares plus US $10.00 in cash.

Did NV5 restricted stock awards vest in the merger?

Yes. All outstanding NV5 restricted stock held by the insider vested immediately before the merger and received the same consideration.

How many NV5 shares does the insider own after the transaction?

The filing shows 0 NV5 shares beneficially owned following the merger conversion.

Why was the transaction code 'D' used in the Form 4?

Code D denotes a disposition of issuer securities—here, the mandatory exchange of NV5 shares for Acuren shares and cash.